Por: New York Post Life December 13, 2022
The — Laser-Assisted In Situ Keratomileusis — is under the lens of the Food and Drug Administration (FDA), which is causing controversy among eye experts. The FDA released a 25-page draft guidance after receiving input from patients who felt they were not fully informed of the , the agency stated on its website. The FDA’s guidance states that patients considering LASIK surgery should be given a “decision checklist” that describes... + full article
ABC News USA Life December 08, 2022
The is weighing whether or not surgeons should provide additional warnings about the risks of , a popular corrective eye-sight surgery.In a draft guidance from July, the agency suggested that patients should be explicitly informed about the risks of dry eye, problems driving at... + más
FDA warns that LASIK surgery patients need to be better informed of risks before procedure | New York Post
Lasik patients should be warned of complications, FDA draft says | The Boston Globe
The Boston Globe USA Nation December 08, 2022
Patients considering Lasik surgery should be warned that they may be left with double vision, dry eyes, difficulty driving at night, and, in rare cases, persistent eye pain, according to draft guidance by the Food and Drug Administration. After surgery, patients might still need... + más
FDA weighs whether Lasik patients should be given extra warning about possible risks | ABC News
Lasik Patients Should Be Warned of Complications, F.D.A. Draft Says | The New York Times
The New York Times USA Health December 07, 2022
Patients considering Lasik surgery should be warned that they may be left with double vision, dry eyes, difficulty driving at night and, in rare cases, persistent eye pain, according to draft guidance by the Food and Drug Administration. After surgery, patients may still need... + más
ABC News USA Health September 30, 2022
WASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.Amylyx Pharmaceuticals said the Food and... + más
Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post
ALS drug wins FDA approval despite questionable data | WPLG Local 10
WPLG Local 10 USA Politics September 30, 2022
WASHINGTON – A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más
ALS drug wins FDA approval despite questionable data | ABC News
Associated Press USA Science September 30, 2022
WASHINGTON (AP) — A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration... + más
NBC 6 South Florida USA World September 30, 2022
Al Drago/CQ Roll Call/Getty Images A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines. The Food and Drug... + más
ALS drug wins FDA approval despite questionable data | Portland Press Herald
About iurex | Privacy Policy | Disclaimer |